Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy
Autoantigen-specific immunotherapy using peptides offers a more targeted approach to treat autoimmune diseases, but clinical implementation has been challenging. We previously showed that multivalent delivery of peptides as soluble antigen arrays (SAgA…